2361 — Sinohealth Technology Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- HK$2.27bn
- HK$1.56bn
- CNY419.09m
Annual cashflow statement for Sinohealth Technology Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 95.5 | 54.5 | 111 | 120 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -9.05 | -21.1 | -4.74 | -17.8 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -33.8 | -9.47 | -35.5 | -18.5 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 60 | 32.6 | 79.1 | 91.8 | — |
| Capital Expenditures | -3.05 | -4.18 | -3.41 | -3.42 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -6.42 | 119 | -231 | -75.3 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -9.47 | 114 | -234 | -78.7 | — |
| Financing Cash Flow Items | -192 | -4.83 | -0.695 | -6.82 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -132 | 219 | -133 | -75.7 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -81.8 | 375 | -285 | -60.2 | — |